Atea Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
68.29 |
7.08 |
5.74 |
30.90 |
| Przychód Δ r/r |
0.00% |
-89.63% |
-18.91% |
438.28% |
| Przychód (min) |
68.29 |
7.08 |
5.74 |
30.90 |
| Przychód (max) |
68.29 |
7.08 |
5.74 |
30.90 |
| EBITDA (średnia) |
43.26 |
4.49 |
3.64 |
19.58 |
| EBIT (średnia) |
43.26 |
4.48 |
3.64 |
19.57 |
| EBIT % |
63.34% |
63.34% |
63.34% |
63.34% |
| Zysk netto (średni) |
-153.16 |
-182.85 |
-144.09 |
-113.34 |
| Zysk netto % |
-224.28% |
-2582.74% |
-2509.79% |
-366.74% |
| EPS (średnia) |
-1.80 |
-2.17 |
-1.71 |
-1.34 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
2 |
1 |
1 |
| symbol |
AVIR |
AVIR |
AVIR |
AVIR |